AIDX today
$0.22+$0.03 (+13.75%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minDescending Triangle
5 minStrong Bullish
Daily trend turns up above $0.26
Key levels
Resistance$0.40
Resistance$0.26
Support$0.21
About 20/20 Biolabs
20/20 Biolabs develops and sells laboratory blood tests for early cancer and chronic disease detection. Its main products are the OneTest for Cancer multi-cancer screening test and a longevity panel that tracks inflammation markers, both run at its own clinical lab in Gaithersburg, Maryland. The company also sells BioCheck, a portable field tool used to check questionable substances for bioterror pathogens, and rents shared lab space to overseas diagnostics startups. Customers include consumers, firefighters, self-insured employers, and healthcare providers in the United States.
Based on the company's 10-K filed Mar 31, 2026.
Nasdaq · Healthcare
20/20 Biolabs, Inc. (AIDX)
What Is the Price Target for AIDX?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is AIDX a Buy or Sell Right Now?
Thesis
- •Revenue growing 16.7% YoY with UNKNOWN trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AIDX.
Start Free Trial →Is AIDX Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
23
Moat Score
NONE
4/9
Piotroski Score
-13.5
Altman Z-Score
What Is Smart Money Doing with AIDX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →AIDX Growth Story
Revenue YoY
16.7%
3yr Revenue CAGR
N/A%
EPS Growth YoY
34.48%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for AIDX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for AIDX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 23:47:28 | $0.20 | 5,370 | $$1K | SELL |
| 22:02:18 | $0.21 | 1,900 | $$402 | SELL |
| 22:02:14 | $0.21 | 2,500 | $$533 | BUY |
| 21:05:09 | $0.22 | 1,800 | $$401 | BUY |
| 21:05:04 | $0.22 | 1,000 | $$223 | BUY |
5 dark pool trades shown · $$3K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for 20/20 Biolabs, Inc. (AIDX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →AIDX — frequently asked questions
What is AIDX stock price today?
20/20 Biolabs, Inc. (AIDX) is at $0.22, up 13.75% (+$0.03) at the Nov 11, 2026 close.
Why is AIDX stock moving today?
Latest AIDX news — Nov 10, 2026: HEALWELL AI Posts Q3 2026 Results
What do analysts rate AIDX?
Analyst ratings for AIDX: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did AIDX beat earnings?
AIDX last reported on Aug 17, 2026: EPS -$0.26 vs -$0.12 expected — a miss of 116.7%.
Does AIDX pay a dividend?
AIDX does not currently pay a dividend.
What are AIDX support and resistance levels?
Support: $0.21. Resistance: $0.26, $0.40, $0.50.
What are insiders doing with AIDX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on AIDX?
Nov 10, 2026: HEALWELL AI Posts Q3 2026 Results